Woodline Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Woodline Partners's EXAS Position: Q1 2026 in Review
Woodline Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,496,795 shares — an estimated $152M sold.
Woodline Partners first reported a position in EXAS in Q2 2020 and held it in 15 quarters. The position peaked at $152M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Woodline Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Woodline Partners sold 1,496,795 Exact Sciences shares in Q1 2026, an estimated $152M.
- Woodline Partners first reported a position in Exact Sciences in Q2 2020 and held it in 15 quarters.
- Woodline Partners's Exact Sciences position peaked at $152M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.